Breaking News

Akiram, Swedish Hospital Enter Radiotherapy Mfg. Pact

Karolinska will supply Akiram with services related to cGMP production of the radiopharmaceutical product 177Lu-AKIR001.

Akiram Therapeutics, a biotech company specializing in targeted radiotherapy, has entered into an agreement with Karolinska University Hospital in Solna, Sweden for the manufacturing of 177Lu-AKIR001, a radiopharmaceutical designed to treat solid tumors. A Phase I first-in-human study is planned to start in 2024. Karolinska will supply Akiram with services related to cGMP production of the radiopharmaceutical product 177Lu-AKIR001 for human use, along with other related services. The hospital...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters